Asthma News – March 21 to 22, 2018

Current asthma research, announcements and opportunities, collected and distributed by Michigan Department of Health & Human Services Asthma Program Staff.

Emergency asthma, allergy management in schools inadequate

Physician input may improve the care of asthma exacerbations and anaphylaxis in the school setting because emergency action plans are maintained by only approximately 41% of children with allergies and 21% of children with asthma, according to a new study.

Reviews Reveal Benefits of LAMAs, LABAs, and SMART in Asthma

Updated evidence on effective asthma management and step-up therapy provide a more precise understanding of the relative efficacy of regimens involving inhaled corticosteroids, long-acting muscarinic antagonists (LAMAs), long-acting β-agonists (LABAs), and single maintenance and reliever therapy (SMART), according to two meta-analyses and systematic reviews.

Is There A Link Between Asthma And Depression?

Using data from the Swedish Twin Registry, researchers found that of the 1,465 twins with a diagnosis of asthma, 25% also suffered from a severe depression and around 7% from an anxiety disorder, but genes seem to play a minor role.

New JAMA Study Identifies Effective Treatments for Persistent Asthma

When it comes to treating teens and adults with persistent asthma, using a single corticosteroid and long-acting bronchodilator treatment for both daily asthma control and for rescue relief during sudden asthma attacks is more effective than taking separate medications for daily control and rescue.

Dupilumab controls atopic dermatitis symptoms in patients with asthma

Adults with moderate to severe atopic dermatitis (AD) and asthma experience the same improvement in AD symptoms with dupilumab treatment as those without asthma, according to two large phase 3 clinical trials.

Asthma Control & Management: Building a Brighter Future - May 17 at 2:15 - Live Simulcast - Earn CMEs

Join expert faculty as they review how the heterogeneous nature of the disease impacts the diagnosis, assessment, and management of asthma. Recognize the strengths and limitations of current guideline recommendations, and review the available and emerging pharmacologic treatments for asthma in order to control the disease. Lastly, appropriate use of each inhaler class will be demonstrated.

EPA Asthma Webinar Series: Asthma 101 - April 4 at 1 p.m.

This webinar covers asthma basics, including basic physiology of asthma and asthma episodes, statistics of asthma prevalence, the role of the EPA and other Federal Agencies, triggers and some actions that can be taken in the healthy homes framework.